Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis (original) (raw)

• Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson Jr CP . (2003). QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162: 341–351.
  Article CAS PubMed PubMed Central Google Scholar
• Ai X, Kitazawa T, Do A-T, Kusche-Gullberg M, Labosky PA, Emerson Jr CP . (2007). SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 134: 3327–3338.
  Article CAS PubMed Google Scholar
• Aikawa T, Whipple CA, Lopez ME, Gunn J, Young A, Lander AD et al. (2008). Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J Clin Invest 118: 89–99.
  Article CAS PubMed Google Scholar
• Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S et al. (2000). Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25: 329–332.
  Article CAS PubMed Google Scholar
• Bafico A, Liu G, Goldin L, Harris V, Aaronson SA . (2004). An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6: 497–506.
  Article CAS PubMed Google Scholar
• Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J et al. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729–777.
  Article CAS PubMed Google Scholar
• Bishop JR, Schuksz M, Esko JD . (2007). Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446: 1030–1037.
  Article CAS PubMed Google Scholar
• Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE . (1998). Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273: 4350–4359.
  Article CAS PubMed Google Scholar
• Capurro MI, Xiang YY, Lobe C, Filmus J . (2005). Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65: 6245–6254.
  Article CAS PubMed Google Scholar
• Castro NP, Osorio CA, Torres C, Bastos EP, Mourao-Neto M, Soares FA et al. (2008). Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10: R87.
  Article PubMed PubMed Central Google Scholar
• Clevers H . (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480.
  Article CAS PubMed Google Scholar
• Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z et al. (2005). HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem 280: 40066–40073.
  Article CAS PubMed Google Scholar
• Danesin C, Agius E, Escalas N, Ai X, Emerson C, Cochard P et al. (2006). Ventral neural progenitors switch toward an oligodendroglial fate in response to increased Sonic Hedgehog (Shh) activity: involvement of sulfatase 1 in modulating Shh signaling in the ventral spinal cord. J Neurosci 26: 5037–5048.
  Article CAS PubMed PubMed Central Google Scholar
• DeAlmeida VI, Miao L, Ernst JA, Koeppen H, Polakis P, Rubinfeld B . (2007). The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res 67: 5371–5379.
  Article CAS PubMed Google Scholar
• Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH et al. (2002). Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem 277: 10982–10986.
  Article CAS PubMed Google Scholar
• Derksen PW, Tjin E, Meijer HP, Klok MD, MacGillavry HD, van Oers MH et al. (2004). Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 101: 6122–6127.
  Article CAS PubMed PubMed Central Google Scholar
• Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson Jr CP . (2001). Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293: 1663–1666.
  Article CAS PubMed Google Scholar
• Esko JD, Lindahl U . (2001). Molecular diversity of heparan sulfate. J Clin Invest 108: 169–173.
  Article CAS PubMed PubMed Central Google Scholar
• Freeman SD, Moore WM, Guiral EC, Holme AD, Turnbull JE, Pownall ME . (2008). Extracellular regulation of developmental cell signaling by XtSulf1. Dev Biol 320: 436–445.
  Article CAS PubMed Google Scholar
• Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J et al. (2000). Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 156: 1997–2005.
  Article CAS PubMed PubMed Central Google Scholar
• Fuster MM, Esko JD . (2005). The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5: 526–542.
  Article CAS PubMed Google Scholar
• Gallagher JT . (2001). Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108: 357–361.
  Article CAS PubMed PubMed Central Google Scholar
• Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ et al. (2006). Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res 8: R56.
  Article PubMed PubMed Central Google Scholar
• Groen RWJ, Oud MECM, Schilder-Tol EJM, Overdijk MB, ten Berge D, Nusse R et al. (2008). Illegitimate WNT pathway activation by {beta}-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 68: 6969–6977.
  Article CAS PubMed Google Scholar
• Habuchi H, Habuchi O, Kimata K . (2004). Sulfation pattern in glycosaminoglycan: does it have a code? Glycoconj J 21: 47–52.
  Article CAS PubMed Google Scholar
• Habuchi H, Nagai N, Sugaya N, Atsumi F, Stevens RL, Kimata K . (2007). Mice deficient in heparan sulfate 6-_O_-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem 282: 15578–15588.
  Article CAS PubMed Google Scholar
• Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R et al. (2004). Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 109: 106–111.
  Article CAS PubMed Google Scholar
• Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S et al. (2007). Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS ONE 2: e575.
  Article PubMed PubMed Central Google Scholar
• Hossain MM, Hosono T, Tang R, van Kuppevelt TH, Jenniskens GJ, Rosen SD et al. (2009). Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88. Glycobiology (e-pub ahead of print 12 October 2009).
• Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H et al. (2008). Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer 44: 2680–2688.
  Article CAS PubMed Google Scholar
• Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL . (1994). Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res 54: 2615–2621.
  CAS PubMed Google Scholar
• Janssens N, Andries L, Janicot M, Perera T, Bakker A . (2004). Alteration of frizzled expression in renal cell carcinoma. Tumour Biol 25: 161–171.
  Article CAS PubMed Google Scholar
• Johansson FK, Brodd J, Eklof C, Ferletta M, Hesselager G, Tiger CF et al. (2004). Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci USA 101: 11334–11337.
  Article CAS PubMed PubMed Central Google Scholar
• Kawano Y, Kypta R . (2003). Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627–2634.
  Article CAS PubMed Google Scholar
• Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B et al. (2007). Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 133: 733–737.
  Article CAS PubMed Google Scholar
• Klaus A, Birchmeier W . (2008). Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387–398.
  Article CAS PubMed Google Scholar
• Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H, Gaffney PM et al. (2006). Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928–6935.
  Article CAS PubMed Google Scholar
• Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA et al. (2003). Loss of HSulf-1 upregulates heparin-binding growth factor signaling in cancer. J Biol Chem 278: 23107–23117.
  Article CAS PubMed Google Scholar
• Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP et al. (2004). hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 126: 231–248.
  Article CAS PubMed Google Scholar
• Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK et al. (2008). Sulfatase 2 upregulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 47: 1211–1222.
  Article CAS PubMed Google Scholar
• Lamanna WC, Frese MA, Balleininger M, Dierks T . (2008). Sulf loss influences _N_-, 2-_O_-, and 6-_O_-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem 283: 27724–27735.
  Article CAS PubMed Google Scholar
• Langsdorf A, Do AT, Kusche-Gullberg M, Emerson Jr CP, Ai X . (2007). Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev Biol 311: 464–477.
  Article CAS PubMed Google Scholar
• Lemjabbar-Alaoui H, Dasari V, Sidhu SS, Mengistab A, Finkbeiner W, Gallup M et al. (2006). Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS ONE 1: e93.
  Article PubMed PubMed Central Google Scholar
• Li J, Kleeff J, Abiatari I, Kayed H, Giese NA, Felix K et al. (2005). Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Mol Cancer 4: 14.
  Article PubMed PubMed Central Google Scholar
• Logan CY, Nusse R . (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810.
  Article CAS PubMed Google Scholar
• Lum DH, Tan JH, Rosen SD, Werb Z . (2006). Gene trap disruption of the mouse heparan sulfate 6-O endosulfatase, Sulf2. Mol Cell Biol 27: 678–688.
  Article PubMed PubMed Central Google Scholar
• Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I et al. (2004). Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717–4720.
  Article CAS PubMed Google Scholar
• Mikami I, You L, He B, Xu Z, Batra S, Lee AY et al. (2005). Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer 5: 53.
  Article PubMed PubMed Central Google Scholar
• Miller JR, Hocking AM, Brown JD, Moon RT . (1999). Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860–7872.
  Article CAS PubMed Google Scholar
• Morimoto-Tomita M, Uchimura K, Bistrup A, Lum DH, Egeblad M, Boudreau N et al. (2005). Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia 7: 1001–1010.
  Article CAS PubMed PubMed Central Google Scholar
• Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD . (2002). Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277: 49175–49185.
  Article CAS PubMed Google Scholar
• Nakashima T, Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M et al. (2008). Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol Rep 19: 203–209.
  PubMed Google Scholar
• Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, Rosen SD . (2007). Extracellular sulfatases, elements of the wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS ONE 2: e392.
  Article PubMed PubMed Central Google Scholar
• Ohgaki H, Kros JM, Okamoto Y, Gaspert A, Huang H, Kurrer MO . (2004). APC mutations are infrequent but present in human lung cancer. Cancer Lett 207: 197–203.
  Article CAS PubMed Google Scholar
• Osada H, Takahashi T . (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21: 7421–7434.
  Article CAS PubMed Google Scholar
• Parish CR, Freeman C, Hulett MD . (2001). Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471: M99–M108.
  CAS PubMed Google Scholar
• Ratzka A, Kalus I, Moser M, Dierks T, Mundlos S, Vortkamp A . (2008). Redundant function of the heparan sulfate 6-_O_-endosulfatases Sulf1 and Sulf2 during skeletal development. Dev Dyn 237: 339–353.
  Article CAS PubMed Google Scholar
• Sato M, Shames DS, Gazdar AF, Minna JD . (2007). A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2: 327–343.
  Article PubMed Google Scholar
• Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE . (2007). Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 9: R63.
  Article PubMed PubMed Central Google Scholar
• Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268–274.
  Article PubMed Google Scholar
• Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J . (2001). Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30: 316–321.
  Article CAS PubMed Google Scholar
• Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD et al. (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417–422.
  Article CAS PubMed Google Scholar
• Tang R, Rosen SD . (2009). Functional consequences of the subdomain organization of the sulfs. J Biol Chem 284: 21505–21514.
  Article CAS PubMed PubMed Central Google Scholar
• Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J et al. (2006). HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 7: 2.
  Article PubMed PubMed Central Google Scholar
• Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM . (2003). Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22: 7218–7221.
  Article CAS PubMed Google Scholar
• Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S . (2004). Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem 279: 5604–5611.
  Article CAS PubMed Google Scholar
• Vlodavsky I, Ilan N, Naggi A, Casu B . (2007). Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13: 2057–2073.
  Article CAS PubMed Google Scholar
• Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, Kessler DS et al. (2004). QSulf1, a heparan sulfate 6-_O_-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci USA 101: 4833–4838.
  Article CAS PubMed PubMed Central Google Scholar
• Winn RA, Van Scoyk M, Hammond M, Rodriguez K, Crossno Jr JT, Heasley LE et al. (2006). Antitumorigenic Effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor {gamma}. J Biol Chem 281: 26943–26950.
  Article CAS PubMed Google Scholar
• You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I et al. (2004). Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170–6174.
  Article CAS PubMed Google Scholar